Traci Miller on How Hybrid Hub Models Redefine Pharma Partnerships

The role of hub services is undergoing a fundamental shift. No longer confined to administrative tasks like benefits verification and prior authorizations, today’s hybrid hub models are evolving into highly coordinated ecosystems—requiring deeper collaboration across manufacturers, distributors, specialty pharmacies, and service providers. That transformation is reshaping not just workflows, but the very nature of partnership across the access landscape.

In the first part of her video interview with Pharmaceutical Commerce, Traci Miller, senior director of Access and Patient Support at Sonexus, offers a firsthand perspective on how these dynamics are playing out in real time. Drawing on her experience in hybrid hub models, Miller explains how manufacturers are moving away from transactional vendor relationships toward more integrated, strategic partnerships—often involving a dozen or more stakeholders working in tandem.

At the same time, automation is accelerating access in ways that were previously out of reach. From fully digital intake and benefits investigation to streamlined prior authorization processes, technology is dramatically reducing timelines and operational burden. But as Miller emphasizes, efficiency gains don’t eliminate the need for human connection—particularly when supporting patients navigating increasingly complex therapies. Instead, the future of patient support lies in striking the right balance between digital scale and human empathy.